HCW Biologics Inc.
HCWB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828673
In the last 90 days, HCW Biologics Inc. insiders filed 3 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $515.7K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding HCW Biologics Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 9 | +9 |
| Shares | 0 | 160.6K | +160.6K |
| Value | $0 | $512.0K | +$512.0K |
New holders (9)
Institutions that held HCW Biologics Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 45,416 | $145.0K | 0.00% |
| UBS Group AG | 37,384 | $119.0K | 0.00% |
| Geode Capital Management, LLC | 21,362 | $68.0K | 0.00% |
| Goldman Sachs Group Inc | 19,785 | $63.0K | 0.00% |
| BlackRock Inc. | 16,279 | $52.0K | 0.00% |
| HighTower Advisors, LLC | 14,000 | $45.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 5,837 | $18.0K | 0.00% |
| Morgan Stanley | 500 | $2.00K | 0.00% |
| Wells Fargo & Company | 44 | $0 | 0.00% |
Sold out (0)
Institutions that held HCW Biologics Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.